The store will not work correctly when cookies are disabled.
3-((3-(Methylthio)phenyhamino)-4-(2-(trifluoromethyl)phenyl)-1H-pyrrole-2,5-dione
ID: ALA4860051
PubChem CID: 164611526
Max Phase: Preclinical
Molecular Formula: C18H13F3N2O2S
Molecular Weight: 378.38
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CSc1cccc(NC2=C(c3ccccc3C(F)(F)F)C(=O)NC2=O)c1
Standard InChI: InChI=1S/C18H13F3N2O2S/c1-26-11-6-4-5-10(9-11)22-15-14(16(24)23-17(15)25)12-7-2-3-8-13(12)18(19,20)21/h2-9H,1H3,(H2,22,23,24,25)
Standard InChI Key: WZKDNUBCZPPEKK-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
15.3657 -14.7466 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.3698 -15.5638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0754 -15.1516 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
17.0073 -15.6041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8245 -15.6041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0788 -14.8274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4159 -14.3453 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7571 -14.8274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5828 -16.3024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7635 -16.2825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3385 -16.9811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7316 -17.6999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5541 -17.7158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9754 -17.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3040 -16.2658 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1173 -16.2654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5225 -16.9719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3350 -16.9718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7422 -16.2668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3308 -15.5603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5196 -15.5638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8564 -14.5759 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.9798 -14.5752 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.5548 -15.5461 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.7436 -17.6795 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
21.5608 -17.6796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 1 0
7 8 1 0
8 4 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
9 4 1 0
5 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
6 22 2 0
8 23 2 0
10 2 1 0
2 24 1 0
18 25 1 0
25 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 378.38 | Molecular Weight (Monoisotopic): 378.0650 | AlogP: 3.91 | #Rotatable Bonds: 4 |
Polar Surface Area: 58.20 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.67 | CX Basic pKa: ┄ | CX LogP: 3.45 | CX LogD: 3.45 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.63 | Np Likeness Score: -0.90 |
References
1. Serafim RAM, Sorrell FJ, Berger BT, Collins RJ, Vasconcelos SNS, Massirer KB, Knapp S, Bennett J, Fedorov O, Patel H, Zuercher WJ, Elkins JM.. (2021) Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold., 64 (18.0): [PMID:34463505] [10.1021/acs.jmedchem.0c01579] |